Of upregulated cytokines, 5 were involved in glioma growth, including CXCL10, CXCL1, CCL2, and CCL5 and IL-6, with 1, tissue inhibitor of metalloproteinase 1 (TIMP-1), being involved in matrix degradation. The gene discussed is TIMP1; the disease is glioma.